Dopamine-Serotonin Transporter Disease

J Gordon Millichap

doi:10.15844/pedneurbriefs-27-4-1

Dopamine-Serotonin Transporter Disease

Pediatric Neurology Briefs

Volume 27 (2013): Issue 4

By: J Gordon Millichap

Open Access

|Apr 2013

Abstract

Investigators at the Hospital for Sick Children, University of Toronto, Canada report 8 children of a consanguineous Saudi Arabian family who had a similar movement disorder, with autosomal recessive inheritance and a mutation in the SLC18A2 gene that encodes vesicular monoamine transporter 2 [VMAT2].

References

Rilstone JJ Alkhater RA Minassian BA Brain dopamine-serotonin vesicular transporter disease and its treatment N Engl J Med 2013 Feb 7 386 6 543 50 10.1056/NEJMoa1207281 23363473
Open DOI Search in Google Scholar Back to article
Kurian MA Gissen P Smith M Heales S Jr Clayton PT The monoamine neurotransmitter disorders: an expanding range of neurological syndromes Lancet Neurol 2011 Aug 10 8 721 33 10.1016/S1474-4422(11)70141-7 21777827
Open DOI Search in Google Scholar Back to article
Ropper AH Samuels MA Adams and Victor’s Principles of Neurology 2009 9th edition 1041 42 McGraw Hill Medical New York
Search in Google Scholar Back to article
Patrick PD Blackman JA Mabry JL Buck ML Gurka MJ Conaway MR Dopamine agonist therapy in low-response children following traumatic brain injury J Child Neurol 2006 Oct 21 10 879 85 10.1177/08830738060210100901 17005105
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-27-4-1 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 25 - 26

Published on: Apr 1, 2013

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Norepinephrine,

Neurologic Examination,

Dopamine Agonists

© 2013 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 27 (2013): Issue 4